Patents - stay tuned to the technology

Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Specklin

Jean-Luc Specklin, Kembs-Schaferhof FR

Patent application numberDescriptionPublished
20110059946DUAL ACTION ANTIBIOTICS - The present invention relates to compounds of the Formula (I) that are useful antimicrobial agents and effective against a variety of multi-drug resistant bacteria:03-10-2011

Jean-Luc Specklin, Kembs FR

Patent application numberDescriptionPublished
200902475785-HYDROXYMETHYL-OXAZOLIDIN-2-ONE-DERIVATIVES AND THEIR USES AS ANTIBACTERIALS - The invention relates to novel chimeric antibiotics of formula I10-01-2009
201000693765-HYDROXYMETHYL-OXAZOLIDIN-2-ONE ANTIBACTERIALS - The invention relates to novel chimeric antibiotics of formula I03-18-2010
20100222302Novel Antibacterial Compounds - The invention relates to novel chimeric antibiotics of formula I09-02-2010

Jean-Luc Specklin, Kembs-Schaeferhof FR

Patent application numberDescriptionPublished
20090306389Intermediate products for producing oxazolidinone-quinolone hybrids - The present invention describes intermediates (ZP) for a novel and efficient synthesis of compounds in which the pharmacophores of quinolone and oxazolidinone are linked to one another by way of a chemically stable linker.12-10-2009
20120135961USE OF OXAZOLIDINONE-QUINOLINE HYBRID ANTIBIOTICS FOR THE TREATMENT OF ANTHRAX AND OTHER INFECTIONS - The present invention relates to the use of compounds, in which the pharmacophores of quinolone and oxazolidinone are chemically linked together through a linker that is stable under physiological conditions, for the treatment of anthrax and other infections.05-31-2012
20120142635OXAZOLIDINONE-QUINOLONE HYBRID ANTIBIOTICS - The present invention relates to compounds of the Formula (I) that are useful antimicrobial agents and effective against a variety of multi-drug resistant bacteria:06-07-2012
20120322766USE OF OXAZOLIDINONE-QUINOLINE HYBRID ANTIBIOTICS FOR THE TREATMENT OF ANTHRAX AND OTHER INFECTIONS - The present invention relates to the use of compounds, in which the pharmacophores of quinolone and oxazolidinone are chemically linked together through a linker that is stable under physiological conditions, for the treatment of anthrax and other infections.12-20-2012
20130296275OXAZOLIDINONE-QUINOLONE HYBRID ANTIBIOTICS - The present invention relates to compounds of the Formula (I) that are useful antimicrobial agents and effective against a variety of multi-drug resistant bacteria:11-07-2013

Patent applications by Jean-Luc Specklin, Kembs-Schaeferhof FR

Website © 2015 Advameg, Inc.